Core Viewpoint - Aomei Medical announced the appointment of several senior management positions during the first meeting of the fourth board of directors, indicating a strategic move to strengthen its leadership team [1] Group 1: Management Appointments - The company appointed Mr. Cui Jinhai as the President, Mr. Zheng Xiaocheng as the Board Secretary, and several Vice Presidents including Ms. Cheng Hong, Mr. Cui Hui, Mr. Cui Xingwei, Ms. Chen Chunqing, and Mr. Huang Tiezhu [1] - Mr. Huang Tiezhu was also appointed as the Chief Financial Officer, while Mr. Wang Yuandong was appointed as the Securities Affairs Representative to assist the Board Secretary [1] Group 2: Financial Performance - For the first half of 2025, Aomei Medical's revenue composition was 94.13% from medical devices and 5.87% from other sources [1] - The company's market capitalization is currently valued at 8 billion yuan [1]
奥美医疗:聘任崔金海为公司总裁